22 May 2013
Keywords: amgen, genentech, deal, antibody, patents, biotechnology, majors
Article | 30 January 2006
US biotechnology majors Amgen and Genentech say they have entered into license deal granting rights to each other under multiple ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 January 2006
6 February 2006
21 May 2013
© 2013 thepharmaletter.com